Ep Wealth Advisors, LLC Biogen Inc. Transaction History

Ep Wealth Advisors, LLC

$14.6 Billion
Q2 2025

A detailed history of Ep Wealth Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 4,614 shares of BIIB stock, worth $694,084. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,614

Previous 4,384 5.25%

Holding current value

$694,084

Previous $599,000 3.34%

% of portfolio

0.0%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$113.38 - $135.49 $26,077 - $31,162	230 Added 5.25%	4,614 $579,000
Q1 2025 May 15, 2025	SELL	$133.43 - $153.27 $934 - $1,072	-7 Reduced 0.16%	4,384 $599,000
Q4 2024 Feb 13, 2025	BUY	$146.47 - $191.55 $44,087 - $57,656	301 Added 7.36%	4,391 $671,000
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $773,296 - $968,512	4,090 New	4,090 $792,000
Q2 2019 Aug 27, 2019	SELL	$219.29 - $241.72 $8.71 Million - $9.6 Million	-39,706 Closed	0 $0
Q1 2019 May 20, 2019	BUY	$216.71 - $338.96 $322,247 - $504,033	1,487 Added 3.89%	39,706 $9.39 Million
Q4 2018 Feb 19, 2019	SELL	$278.5 - $352.75 $199,684 - $252,921	-717 Reduced 1.84%	38,219 $11.5 Million
Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $79,541 - $104,017	271 Added 0.7%	38,936 $13.8 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $939,947 - $1.12 Million	3,650 Added 10.42%	38,665 $11.2 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $648,764 - $917,567	2,494 Added 7.67%	35,015 $9.59 Million
Q4 2017 Feb 15, 2018	BUY	$307.64 - $344.58 $10 Million - $11.2 Million	32,521	32,521 $10.4 Million

Others Institutions Holding BIIB

# of Institutions

1,031

Shares Held

131M

Call Options Held

2.84M

Put Options Held

2.54M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ep Wealth Advisors, LLC with notifications on news.

Account

Ep Wealth Advisors, LLC Biogen Inc. Transaction History